(Q36231929)

English

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

phase III clinical trial

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

22

object named as

Mark Emberton

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Christian G Stief

7

object named as

Christian G Stief

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Derek J Rosario

object named as

Derek J Rosario

13

1 reference

ORCID Public Data File 2021

3

object named as

Eric Barret

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

author name string

Abdel-Rahmène Azzouzi

1

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sébastien Vincendeau

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Antony Cicco

4

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

François Kleinclauss

5

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Henk G van der Poel

6

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Jens Rassweiler

8

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Georg Salomon

9

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Eduardo Solsona

10

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Antonio Alcaraz

11

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Teuvo T Tammela

12

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Francisco Gomez-Veiga

14

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Göran Ahlgren

15

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Fawzi Benzaghou

16

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Bertrand Gaillac

17

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Billy Amzal

18

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Frans M J Debruyne

19

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Gaëlle Fromont

20

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Christian Gratzke

21

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

PCM301 Study Group

23

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

publication date

19 December 2016

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

181-191

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of low risk prostate cancer: active surveillance and focal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of focal therapy in the management of localised prostate cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedure

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A new contemporary prostate cancer grading system.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial Gland Ablation for Prostate Cancer: Report of a Food and Drug Administration, American Urological Association, and Society of Urologic Oncology Public Workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Personalizing the Use of Active Surveillance As an Initial Approach for Men With Newly Diagnosed Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Can we deliver randomized trials of focal therapy in prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2816%2930661-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(16)30661-1

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

release_3pemfks6vvc77etpgn635ljgpq

1 reference

https://api.fatcat.wiki/v0/release/3pemfks6vvc77etpgn635ljgpq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36231929&oldid=2010634988"